J&J Can’t Escape $110M Verdict In Mo. Talc Cancer Trial

Law360, New York (November 30, 2017, 3:34 PM EST) -- A Missouri state judge on Wednesday upheld a jury’s $110 million verdict against Johnson & Johnson for allegedly selling ovarian cancer-causing products, saying the conduct on which the claims are based occurred in Missouri even though the woman who brought them is from Virginia.

Judge Rex M. Burlison of the 22nd Judicial Circuit Court of Missouri determined the verdict in favor of Lois Slemp met the stricter jurisdictional standards established by the Supreme Court’s June ruling in Bristol-Myers Squibb Co. v. Superior Court of California because J&J used the Union, Missouri-based company PharmaTech to “manufacture, mislabel and package” the products at...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS